# Chicago Clinical Trials Unit

> **NIH AI UM1** · NORTHWESTERN UNIVERSITY · 2026 · $615,750

## Abstract

Project Summary. The Chicago Clinical Trials Unit (CCTU) is a consortium of four Clinical Research Sites
(CRSs) which will address two priority clinical research areas of the NIAID: 1) adult HIV/AIDS therapeutic
strategies, including novel therapeutics, HIV cure, noninfectious comorbidities, and infectious comorbidities
of hepatitis B and tuberculosis; and 2) integrated HIV prevention strategies, including novel long-acting ARVbased
HIV prevention agents and delivery systems for Pre-exposure Prophylaxis (PrEP), multi-purpose
prevention technologies, integrated biomedical and socio-behavioral HIV prevention strategies, and
collaborative protocols with the HIV Vaccines Network testing antibody-mediated prevention strategies. The
CCTU consists of four highly experienced and scientifically productive CRSs that are uniquely positioned to
develop, implement and adapt the clinical research priorities of the NIAID clinical research priority areas. The
CCTU has a proven track record and will continue its productivity through active engagement with
communities affected by HIV that includes participation in high impact, ground-breaking clinical research
studies, efficient management of resources and critical performance oversight of clinical activities,
laboratories, and pharmacies. Compliance with all relevant rules and regulations is a priority of the
consortium. The CCTU includes CRSs and personnel that have long-term productive involvement with the
two research networks with which the CCTU is affiliated, and platforms for inter-network collaboration with
the other NIAID networks. The CRSs and their network affiliations are: Northwestern University (adult
HIV/AIDS therapeutic strategies); Rush University (adult HIV/AIDS therapeutic strategies); Trinity Health &
Wellness Center (adult HIV/AIDS therapeutic strategies); and The Ruth L. Rothstein CORE Center (HIV
prevention and adult HIV/AIDS therapeutic strategies). The cities of Chicago and Dallas, where the CRSs
are located,

## Key facts

- **NIH application ID:** 11234305
- **Project number:** 5UM1AI069471-20
- **Recipient organization:** NORTHWESTERN UNIVERSITY
- **Principal Investigator:** Chad J Achenbach
- **Activity code:** UM1 (R01, R21, SBIR, etc.)
- **Funding institute:** AI
- **Fiscal year:** 2026
- **Award amount:** $615,750
- **Award type:** 5
- **Project period:** 2007-02-01T00:00:00 → 2027-11-30T00:00:00

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11234305

## Citation

> US National Institutes of Health, RePORTER application 11234305, Chicago Clinical Trials Unit (5UM1AI069471-20). Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/grant/nih/11234305. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*